news roundup
Nominate a colleague with impressive leadership and career intentions—even yourself!—for Pharmaceutical Executive's 2018 Emerging Pharma Leaders Awards. Deadline is June 30th!
| Advertisement
Debunking the Myths of Risk-Based Monitoring for a New Approach to Quality Management
Thursday, June 28, 2018 at 11am EDT | 10am CDT | 4pm BST | 5pm CEST
 Register now |
Updated employee announcements, business news, awards, and recognition in the industry today.
| Advertisement
Predicting Holistic Clinical Trial Cost Should Not Be A Struggle
Ying Jiang Explains What You Need To Know
On Demand
 Learn more |
The Avoca Group announced that it has launched the Diligent Qualification Platform, the clinical research centralized platform for vendor qualification as well as eLuminate, an online learning platform focused on clinical research quality, compliance, and oversight, at the 7th Annual AQC Global Quality Summit.
| Advertisement
FILLING THE GAPS IN SITE SELECTION
What You Don't Know Can Help You
On Demand
 Learn more |
Medidata announced that it has entered into an agreement to acquire SHYFT Analytics, bringing the platform for clinical development together with the platform for commercial and real-world data analytics.
|
|
|
| Advertisement
Driving Product Development and Finding the Fast Track in Early-Phase Oncology Programs
On Demand
 Learn more |
| Advertisement
Is RBM living up to the hype? The state of RBM in clinical development
On Demand
 Learn more |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| Advertisement
The Future of ECOA
On Demand
 Learn more |
|
Articles
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.
| Advertisement
Functional Service Models Reimagined: Integrating services and innovation for accelerated clinical development
On Demand
 Learn more |
A look at home and dosing site considerations.
|
|
Blog Posts
To manage the growing scope and complexity of global disclosure regulations and trial transparency initiatives, companies are advised to create a cross-functional clinical transparency committee.
Liquid biopsy, typically non-invasive blood-based tests for circulating tumor DNA and circulating tumor cells, has been long-hyped as a potential game-changer for cancer treatment.
|
|
RBM
Steve Young looks at the tremendous benefits that organizations stand to reap by effectively implementing the core principles included in the ICH update and the significant opportunities that the application of intelligent analytics and centralized statistical monitoring may present.
|
|
|
Advertisement
Design of Early Phase Clinical Trials: How to Increase Efficiency and Probability of Success?
On Demand
 Learn more |
CluePoints has launched the "CluePoints RBM and ICH E6 (R2) Starter Pack" to help small and medium-sized enterprises achieve regulatory compliance through a "risk-based" approach.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
